AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Issue

Thursday, May 16, 2019


In The News


An experimental lentiviral gene therapy approach that restores immune function offers hope to infants with X-linked severe combined immunodeficiency (X-SCID), a rare disorder caused by mutations in the IL2RG gene. Investigators from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and St. Jude Children’s Research…
Major players from large commercial retailers to diagnostic companies are jumping on the direct-to-consumer (DTC) bandwagon, entering into partnerships to offer consumers at-home tests or in some instances open up testing centers at retail sites.

AACC Alert


Amassing colleagues from around the globe to learn about the latest innovations in clinical laboratory medicine is what Jason Park MD, PhD, DABCC loves most about AACC’s Annual Scientific Meeting & Clinical Lab Expo. “There’s few other meetings with as many professional networking and education opportunities,” according to Park, chair…

CLN Connect


Reducing send out costs for high-volume analytes such as vitamin D testing and urine drug analysis is a big motivator for adopting mass spectrometry (MS) in-house. But beyond these straightforward business cases, “labs often face challenges expanding MS applications, despite the technology’s capability to uniquely address crucial clinical needs,” Yan…

Inside AACC


A new and emerging field in diagnostics, circulating cell-free DNA (cfDNA) analysis, has enormous potential for analyzing a variety of conditions such as diabetes, cardiovascular diseases, organ transplantation, autoimmune diseases, sepsis, trauma, and sports management. However, lack of standardization has limited cfDNA analysis in clinical settings. A special report in…

Practice Management


The U.S. Preventive Services Task Force (USPSTF) has shifted its stance on screening average risk children and pregnant women for lead exposure. Once opposed to screening, this independent panel of primary care and prevention experts is now concluding that there isn’t sufficient evidence to recommend for or against screening in…

World View


Despite the recommendations of multiple guidelines to perform genetic testing of individuals who have breast cancer or ovarian cancer less than one-quarter of women diagnosed with breast cancer in a recent study and fewer than one-third of those diagnosed with ovarian cancer underwent any genetic testing. Yet when tested for…